APPLICATION
ANDA085420
TYPE
ANDA
ORIGINAL APPROVAL
1977-03-10
LATEST ACTION
1977-03-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
HYDROCHLOROTHIAZIDE W/ RESERPINEDiscontinued
HYDROCHLOROTHIAZIDE 50MG, RESERPINE 0.125MG · TABLET · ORAL
Approval history
1977-03-10OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.